Your Face Won't Calm Down. Your Genes May Be Why.

The androgen receptor is the lock that testosterone and DHT fit into. It sits on cells throughout your skin, particularly in sebaceous glands and hair follicles. When androgens bind to this receptor, they tell skin cells to produce more sebum, increase inflammatory responses, and thicken the skin barrier. In other words, the androgen receptor controls how reactive your skin is to hormonal signals.

Here’s the problem: the AR gene has a variable number of CAG repeats. Shorter repeats mean your receptor is more sensitive to androgenic signals. People with shorter CAG repeats (the common genetic variant) have more responsive androgen receptors. That translates to more oil production, more follicular plugging, and paradoxically, more chronic redness because the skin is constantly trying to regulate excess sebaceous activity. Your skin may be locked in a state of overactive response to your own hormones, even if your hormone levels are technically normal.

You probably notice your redness gets worse with hormonal shifts: around your cycle if you menstruate, or during high-stress periods when androgen levels spike. Your skin feels oily and reactive. It reddens easily. Rosacea-like flushing happens without much provocation. That’s your AR-driven skin sensitivity amplifying every minor inflammatory trigger into visible redness.

SRD5A2 encodes an enzyme that sits in your skin cells and converts testosterone into DHT. DHT is the most potent androgenic hormone and the primary driver of sebaceous gland activity. This enzyme is highly active in facial skin, particularly around the nose, cheeks, and forehead.

The V89L variant in SRD5A2, carried by roughly 30-40% of the population, affects how efficiently this conversion happens. Some variants increase DHT production; others decrease it. But when you’re a carrier of the high-activity variant, your skin is manufacturing elevated levels of DHT locally, right where it’s being produced. That means even if your blood testosterone is normal, your skin is bathed in a potent inflammatory and sebum-driving hormone. Your skin cells are responding to higher local DHT than someone without the variant would experience.

This is why you might have persistent redness and oiliness even when your hormone bloodwork comes back normal. Your doctor checked your blood levels. They never looked at what your skin cells were actually producing. You live with chronically reactive, oily, red skin because your local DHT production is engineered to be higher by default.

CYP17A1 is the enzyme that sits at a critical branch point in your hormone pathway. It decides whether your body makes cortisol (the stress hormone) or progresses down the androgen pathway toward testosterone and DHT. This enzyme is expressed throughout your adrenal glands and your skin cells.

Genetic variants in CYP17A1, present in roughly 20-30% of people, affect how active this enzyme is. Variants that increase its activity push your hormone metabolism toward higher androgen production. Your body is preferentially making testosterone and DHT instead of channeling those precursors toward cortisol production. The result is elevated skin androgens with relatively lower cortisol. That’s a state of high sebaceous activity and low anti-inflammatory hormone protection.

You probably notice your redness flares during stress, not because stress is inherently inflammatory (though it is), but because your adrenal system is wired to respond to stress by making more androgens instead of cortisol. That amplifies the very hormone that’s driving your skin inflammation. You’re biochemically stuck in a feedback loop where stress makes your skin worse, and your skin worsens your stress response.

The vitamin D receptor is a protein that sits in the nucleus of almost every cell in your body, including your skin cells. When vitamin D binds to this receptor, it activates genes that control immune tolerance, skin barrier integrity, and the production of antimicrobial peptides that keep your skin balanced. VDR function is essentially the immune system’s off switch for chronic inflammation.

Genetic variants in VDR (the BsmI and FokI polymorphisms), present in roughly 30-50% of the population, reduce the efficiency of this receptor. Your cells are less responsive to vitamin D signaling, meaning you have a weaker brake on inflammatory immune activation even if your vitamin D levels are technically adequate. You might have a blood vitamin D level of 40 ng/mL (considered normal) and still have a VDR that’s not responding effectively to that vitamin D. You’re functionally vitamin D deficient at the cellular level.

This explains why your redness persists even when you supplement vitamin D or spend time in the sun. Your skin cells aren’t receiving the anti-inflammatory message the way they should. Your immune system doesn’t get the signal to calm down. You’re stuck in a state of unregulated inflammatory response because your genetic receptor for the nutrient that should fix it is weak.

TNF-alpha is a protein your immune cells produce when they perceive a threat. It’s pro-inflammatory. It’s supposed to be temporary, a short burst when your body needs to activate immune responses. But TNF-alpha also drives chronic inflammation in skin diseases like rosacea, eczema, and psoriasis. It tells skin cells to produce more inflammatory mediators. It recruits more immune cells to the area. It amplifies the whole inflammatory cascade.

The TNF -308G>A variant, carried by roughly 30% of the population, is associated with higher baseline TNF-alpha production. People with the A allele (the variant) produce more TNF-alpha in response to the same inflammatory trigger that wouldn’t bother someone without it. Your immune system is genetically tuned to overreact with excessive TNF-alpha production. A minor trigger that barely registers for someone else sends your immune system into overdrive, flooding your face with inflammatory cytokines that cause redness, heat, and reactive skin.

You’ve probably noticed your redness responds to stress, certain foods, or weather changes in a way that seems disproportionate to the actual trigger. That’s your TNF-alpha system responding with excessive force. Your face becomes a visible readout of an overactive inflammatory response that your genes have programmed into your immune cells.

Interleukin-6 is another pro-inflammatory cytokine, but it works differently than TNF-alpha. Where TNF-alpha is the initial alarm bell, IL-6 is the signal that keeps the alarm ringing. It maintains chronic inflammation. It activates further immune responses. It tells your body that the problem isn’t resolved yet, keep fighting. In skin conditions, elevated IL-6 means persistent redness, persistent reactivity, persistent inability to return to a calm state.

Genetic variants in IL6 (various polymorphisms in the IL6 promoter region) affect how much IL-6 your immune cells produce under inflammatory conditions. Variant carriers have a genetically higher set point for IL-6 production. Your immune system defaults to a higher chronic inflammatory state because your IL-6-producing cells are more active by genetic design. You can calm your skin down temporarily with a treatment, but IL-6 keeps the underlying inflammation simmering, so redness returns. You’re biochemically stuck in a state of persistent low-grade immune activation.

This is why your redness feels constant. It’s not acute. It’s not triggered by a single thing you can identify. It’s just your baseline. That’s because IL-6 is maintaining a chronic inflammatory state in your skin that your genes have predisposed you toward. Treating the acute flares doesn’t address the chronic signal keeping inflammation alive.